Skip to main content

Articles

Page 53 of 76

  1. MiRNAs was recognized as vital regulators involved in cancer development. Radioresistance remains a major obstacle for effective treatment of cancers. The mechanisms on the miRNA-mediated radioresistance of ca...

    Authors: Chunbao Zang, Fangfang Zhao, Lei Hua and Youguang Pu
    Citation: Cancer Cell International 2018 18:186
  2. Lung cancer is the leading cause of cancer deaths in the world. The major histopathological subtype of lung cancer is non-small cell lung cancer (NSCLC). Platinum-based therapy is the standard of care for pati...

    Authors: Heather E. Kapperman, Alicia A. Goyeneche and Carlos M. Telleria
    Citation: Cancer Cell International 2018 18:185
  3. miRNA clusters are widely expressed across species, accumulating evidence has illustrated that miRNA cluster functioned more efficiently than single miRNA in cancer oncogenesis. It is likely that miRNA cluster...

    Authors: Zhikui Gao, Peng Zhang, Ming Xie, Han Gao, Lihong Yin and Ran Liu
    Citation: Cancer Cell International 2018 18:184
  4. Cervical cancer (CC) is one of the most common cancers among females worldwide. Spindle and kinetochore-associated complex subunit 3 (SKA3), located on chromosome 13q, was identified as a novel gene involved i...

    Authors: Rong Hu, Ming-qing Wang, Wen-bo Niu, Yan-jing Wang, Yang-yang Liu, Ling-yu Liu, Ming Wang, Juan Zhong, Hai-yan You, Xiao-hui Wu, Ning Deng, Lu Lu and Lian-bo Wei
    Citation: Cancer Cell International 2018 18:183
  5. Nuclear transcription factor kappa B (NF-κB) subunits exhibit crucial roles in tumorigenesis and chemo-sensitivity. Recent studies suggest that RelB, the key subunit of the alternative NF-κB pathway, plays a c...

    Authors: Xiaojun Zhou, Zhili Shan, Hengying Yang, Jingjing Xu, Wenjing Li and Feng Guo
    Citation: Cancer Cell International 2018 18:181
  6. With the increasing popularity of water-pipe smoking (WPS), it is critical to comprehend how WPS may affect women’s health. The main goal of this study is to identify the potential outcome of WPS on human brea...

    Authors: Khaled W. Sadek, Mahmoud Y. Haik, Anas A. Ashour, Tahira Baloch, Tahar Aboulkassim, Amber Yasmeen, Semir Vranic, Asad Zeidan and Ala-Eddin Al Moustafa
    Citation: Cancer Cell International 2018 18:180
  7. Some progresses have been made in research of long non-coding RNA (hereunder referred to as LncRNA) related to breast cancer. Lots of data about LncRNA transcription concerning breast cancer have been obtained...

    Authors: Xu Bin, Yang Hongjian, Zhang Xiping, Chen Bo, Yang Shifeng and Tang Binbin
    Citation: Cancer Cell International 2018 18:179
  8. Deregulated Hippo signaling has been uncovered to be intricately involved in tumorigenesis. Transcriptional factor TEADs serve as key mediators of Hippo signaling and have been increasingly appreciated as puta...

    Authors: Wei Zhang, Jin Li, Yaping Wu, Han Ge, Yue Song, Dongmiao Wang, Hua Yuan, Hongbing Jiang, Yanling Wang and Jie Cheng
    Citation: Cancer Cell International 2018 18:178
  9. Sorafenib is the standard targeted drug used to treat hepatocellular carcinoma (HCC), but the therapeutic response between individuals varies markedly. Recently, cytokine-based immunotherapy has been a topic o...

    Authors: Xiaoyan Ding, Wei Sun and Jinglong Chen
    Citation: Cancer Cell International 2018 18:176

    The Retraction Note to this article has been published in Cancer Cell International 2019 19:358

  10. Gao-Min Liu and Yao-Ming Zhang recently published a review entitled «Targeting FBPase is an emerging novel approach for cancer therapy» (Liu and Zhang in Cancer Cell Int 18:36, 2018). In this paper, the authors h...

    Authors: Philippe Icard, Ludovic Fournel, Antoine Coquerel, Joseph Gligorov, Marco Alifano and Hubert Lincet
    Citation: Cancer Cell International 2018 18:175
  11. Pancreatic cancer is characterized by its unsatisfying early detection rate, rapid disease progression and poor prognosis. Further studies on molecular mechanism and novel predictive biomarkers for pancreatic ...

    Authors: Defeng Sun, Haoyi Jin, Jun Zhang and Xiaodong Tan
    Citation: Cancer Cell International 2018 18:174
  12. Cholangiocarcinoma is a highly malignant tumor type that is not sensitive to radiotherapy or chemotherapy due to aggressive perineural invasion and metastasis. Unfortunately, the mechanisms underlying these pr...

    Authors: Yujie Feng, Xiao Hu, Guangwei Liu, Lianfang Lu, Wei Zhao, Fangzhen Shen, Kai Ma, Chuandong Sun, Chengzhan Zhu and Bingyuan Zhang
    Citation: Cancer Cell International 2018 18:173
  13. Galectin-3 as a β-galactoside-binding protein, has been found to be involved in tumor cell growth, anti-apoptosis, adhesion, angiogenesis, invasion, and distant metastases, indicating that it may play a pivota...

    Authors: Yi Wang, Shiwei Liu, Ye Tian, Yamin Wang, Qijie Zhang, Xiang Zhou, Xianghu Meng and Ninghong Song
    Citation: Cancer Cell International 2018 18:172
  14. Breast cancer has been the first death cause of cancer in women all over the world. Metastasis is believed to be the most important process for treating breast cancer. There is evidence that lncRNA MEG3 functions...

    Authors: Xin-Xing Wang, Guang-Cheng Guo, Xue-Ke Qian, Dong-Wei Dou, Zhe Zhang, Xiao-Dong Xu, Xin Duan and Xin-Hong Pei
    Citation: Cancer Cell International 2018 18:171
  15. Cancer metastasis is the major reason for cancer related deaths, and the mechanism of cancer metastasis still unclear. RPLP1, a member of a group of proteins known as ribosomal proteins, is associated with tum...

    Authors: Zhixian He, Qian Xu, Xi Wang, Jun Wang, Xiangming Mu, Yunhui Cai, Yangyang Qian, Weiwei Shao and Zhimin Shao
    Citation: Cancer Cell International 2018 18:170
  16. Gene knockout technologies involving programmable nucleases have been used to create knockouts in several applications. Gene editing using Zinc-finger nucleases (ZFNs), Transcription activator like effectors (...

    Authors: Sumitra Shankar, Ahalya Sreekumar, Deepti Prasad, Ani V. Das and M. Radhakrishna Pillai
    Citation: Cancer Cell International 2018 18:169
  17. Drug resistance prevents the effective treatment of cancers. DNA methylation has been found to participate in the development of cancer drug resistance.

    Authors: Dabing Huang, Yong Wang, Yifu He, Gang Wang, Wei Wang, Xinghua Han, Yubei Sun, Lin Lin, Benjie Shan, Guodong Shen, Min Cheng, Geng Bian, Xiang Fang, Shilian Hu and Yueyin Pan
    Citation: Cancer Cell International 2018 18:168
  18. Inflammation is a major player in breast cancer (BC) progression. Allograft-inflammatory factor-1 (AIF1) is a crucial mediator in the inflammatory response. AIF1 reportedly plays a role in BC, but the mechanis...

    Authors: Ferial Amira Slim, Geneviève Ouellette, Kaoutar Ennour-Idrissi, Simon Jacob, Caroline Diorio and Francine Durocher
    Citation: Cancer Cell International 2018 18:167
  19. Mitochondrial fragmentation drastically regulates the viability of pancreatic cancer through a poorly understood mechanism. The present study used erlotinib to activate mitochondrial fragmentation and then inv...

    Authors: Jun Wan, Jie Cui, Lei Wang, Kunpeng Wu, Xiaoping Hong, Yulin Zou, Shuang Zhao and Hong Ke
    Citation: Cancer Cell International 2018 18:165

    The Retraction Note to this article has been published in Cancer Cell International 2019 19:286

  20. Primary or acquired resistance to cetuximab often occurs during targeted therapy in metastatic colorectal cancer (mCRC) patients. In many cancers, the key role of the long noncoding RNA (lncRNA) urothelial car...

    Authors: Ying-nan Yang, Rui Zhang, Jing-wen Du, Heng-heng Yuan, Yan-jing Li, Xiao-li Wei, Xiao-xue Du, Shu-lin Jiang and Yu Han
    Citation: Cancer Cell International 2018 18:164
  21. Follistatin (FST), an activin-binding protein, inhibits activin action by interfering with activin binding to its receptor. The prognostic value of FST has been studied in various cancers. However, these studi...

    Authors: Pengyu Zhang, Yingxin Ruan, Jun Xiao, Fangfang Chen and Xuejun Zhang
    Citation: Cancer Cell International 2018 18:162
  22. Small cell lung cancer (SCLC) is a highly malignant cancer, and over 70% of patients with SCLC present with the metastatic disease. We aimed to explore some novel differentially expressed genes (DEGs) or micro...

    Authors: Zhonghao Wang, Bei Lu, Lixin Sun, Xi Yan and Jinzhi Xu
    Citation: Cancer Cell International 2018 18:161
  23. In an earlier study, we investigated the expression of tight junction protein claudins (CLDNs) in human osteosarcoma (OS) cells, and the CLDN2 was found to be down-regulated in primary tumor cells compared wit...

    Authors: Xiaowei Zhang, Haiming Wang, Qian Li and Tao Li
    Citation: Cancer Cell International 2018 18:160
  24. While the somatic mutation profiles of renal cell carcinoma (RCC) have been revealed by several studies worldwide, the overwhelming majority of those were not derived from Chinese patients. The landscape of so...

    Authors: Jie Wang, Zhijun Xi, Jianzhong Xi, Hanshuo Zhang, Juan Li, Yuchao Xia and Yuanxue Yi
    Citation: Cancer Cell International 2018 18:159
  25. Osteosarcoma (OS) is one of the most prevalent malignant cancers with lower survival and poor overall prognosis mainly in children and adolescents. Identifying the molecular mechanisms and OS stem cells (OSCs)...

    Authors: Babak Otoukesh, Bahram Boddouhi, Mehdi Moghtadaei, Peyman Kaghazian and Maria Kaghazian
    Citation: Cancer Cell International 2018 18:158
  26. Increasing evidence suggests a critical role for long noncoding RNAs (LncRNAs) and pseudogenes in cancer. Renal cell carcinoma (RCC), the most common primary renal neoplasm, is highly aggressive and difficult ...

    Authors: Binghai Chen, Chengyue Wang, Jin Zhang, Yang Zhou, Wei Hu and Tao Guo
    Citation: Cancer Cell International 2018 18:157
  27. As newly identified Wnt enhancer, R-spondin gene family members have been linked to various cancers; however, their role in isocitrate dehydrogenase-wildtype subtype of human glioblastoma (GBM) cells remains u...

    Authors: Si Liu, Kin Pong U, Jieting Zhang, Lai Ling Tsang, Jiawei Huang, Shui Ping Tu and Xiaohua Jiang
    Citation: Cancer Cell International 2018 18:156
  28. Although mounting non-hereditary colorectal cancer (NHCRC) associated single nucleotide polymorphisms (SNPs) have been observed, no field synopsis and meta-analysis has been conducted through systematically as...

    Authors: Jing Wen, Qian Xu and Yuan Yuan
    Citation: Cancer Cell International 2018 18:155
  29. BORIS (CTCFL) is a DNA binding protein which is involved in tumorigenesis. Although, there are different opinions on the level of gene expression and function of BORIS in normal and cancer tissues, the results...

    Authors: Sara Soltanian and Hesam Dehghani
    Citation: Cancer Cell International 2018 18:154
  30. Chronic inflammation is deemed to play a significant effect on initiation and progression of esophageal squamous cell carcinoma (ESCC). In current study, we investigated the prognostic and predictive role of a...

    Authors: Qiu-Fang Gao, Jia-Cong Qiu, Xiao-Hong Huang, Yan-Mei Xu, Shu-Qi Li, Fan Sun, Jing Zhang, Wei-Ming Yang, Qing-Hua Min, Yu-Huan Jiang, Qing-Gen Chen, Lei Zhang, Xiao-Zhong Wang and Hou-Qun Ying
    Citation: Cancer Cell International 2018 18:153
  31. Several epidemiological researches have indicated that microvessel density (MVD), reflecting angiogenesis, was a negatively prognostic factor of cervical cancer. However, the results were inconsistent. Therefo...

    Authors: Xiaoli Hu, Hailing Liu, Miaomiao Ye and Xueqiong Zhu
    Citation: Cancer Cell International 2018 18:152
  32. Extranodal NK/T-cell lymphoma, nasal type (ENKL) is a distinct clinicopathological entity and EBV-associated disease that is highly aggressive. Many patients had failed to respond to conventional chemotherapy ...

    Authors: Xudong Zhang, Xiaorui Fu, Meng Dong, Zhenzhen Yang, Shaoxuan Wu, Mijing Ma, Zhaoming Li, Xinhua Wang, Ling Li, Xin Li, Zhenchang Sun, Yu Chang, Feifei Nan, Jiaqin Yan, Yun Mao, Mingzhi Zhang…
    Citation: Cancer Cell International 2018 18:150
  33. Marsdenia tenacissima is an herb medicine which has been utilized to treat malignant diseases for decades. The M. tenacissima extract (MTE) shows significant anti-proliferation activity against non-small cell lun...

    Authors: Yan-Na Jiao, Li-Na Wu, Dong Xue, Xi-Juan Liu, Zhi-Hua Tian, Shan-Tong Jiang, Shu-Yan Han and Ping-Ping Li
    Citation: Cancer Cell International 2018 18:149
  34. Arterialized vein flap is a kind of unphysiological flap. Unphysiological reconstruction of blood circulation leads to higher load than that supported by physiological flap and is the culprit of flap swelling,...

    Authors: Zheng Li, Zhen-wei Zhang, Shao-xiao Yu, Jia-chuan Zhuang, Yu-hai Ke, Yi Xiong, Hui-xin Lin and Wen-feng Chen
    Citation: Cancer Cell International 2018 18:148
  35. Drug screening for the identification of compounds with anticancer activity is commonly performed using cell lines cultured under normal oxygen pressure and physiological pH. However, solid tumors are characte...

    Authors: Paola Pellegrini, Jason T. Serviss, Thomas Lundbäck, Nicolo Bancaro, Magdalena Mazurkiewicz, Iryna Kolosenko, Di Yu, Martin Haraldsson, Padraig D’Arcy, Stig Linder and Angelo De Milito
    Citation: Cancer Cell International 2018 18:147
  36. The molecular mechanism of Epstein–Barr virus (EBV)-associated gastric cancer (EBVaGC) remains elusive. A collection of molecular regulators including transcription factor and noncoding RNA (ncRNAs) may affect...

    Authors: Jing-jing Jing, Ze-yang Wang, Hao Li, Li-ping Sun and Yuan Yuan
    Citation: Cancer Cell International 2018 18:146
  37. Ovarian cancer is the fifth leading cause of cancer deaths in women worldwide. LncRNACCAT1 was reported to play a critical role in cell metastasis of ovarian cancer. However, little is known about the detailed me...

    Authors: Yang Mu, Na Li and Yu-Lan Cui
    Citation: Cancer Cell International 2018 18:145
  38. Retinoic acid-induced protein I (RIG-I), known as a cytoplastic pattern recognition receptor, can recognize exogenous viral RNAs, and then initiate immune response. Recently, numerous studies also showed that ...

    Authors: Lujun Chen, Jun Feng, Shaoxian Wu, Bin Xu, You Zhou, Changping Wu and Jingting Jiang
    Citation: Cancer Cell International 2018 18:144
  39. Pancreatic cancer, one of the most aggressive malignancies, ranks the fourth cause of cancer-related death worldwide. Aberrantly expressed long non-coding RNAs (lncRNAs) functioned as oncogenes or tumor suppre...

    Authors: Yong An, Xue-min Chen, Yong Yang, Feng Mo, Yong Jiang, Dong-lin Sun and Hui-hua Cai
    Citation: Cancer Cell International 2018 18:143
  40. Breast cancer is the leading cause of oncological mortality among women. Efficient detection of cancer cells in an early stage and potent therapeutic agents targeting metastatic tumors are highly needed to imp...

    Authors: LingLi Hou, Jiancheng Tu, Fangxiong Cheng, Hongwei Yang, Fei Yu, Minghua Wang, Jiubo Liu, Jinbo Fan and Guojun Zhou
    Citation: Cancer Cell International 2018 18:142
  41. Long non-coding RNA (lncRNA) SNHG5 has been found to play an important role in tumors. Nevertheless, the function and mechanism of lncRNA SNHG5 in osteosarcoma (OS) remains unclear. The purpose of this study w...

    Authors: Cheng Ju, Ruihao Zhou, Jun Sun, Feifei Zhang, Xiaofeng Tang, Kaddie Kwok Chen, Junliang Zhao, Xiaoyong Lan, Shifan Lin, Zhiping Zhang and Xiao-Bin Lv
    Citation: Cancer Cell International 2018 18:141
  42. Aberrant methylation of DNA is a key driver of hepatocellular carcinoma (HCC). In this study, we sought to integrate four cohorts profile datasets to identify such abnormally methylated genes and pathways asso...

    Authors: Guorun Fan, Yaqin Tu, Cai Chen, Haiying Sun, Chidan Wan and Xiong Cai
    Citation: Cancer Cell International 2018 18:140
  43. Both multiple myeloma (MM) and systemic lupus erythematosus (SLE) are associated with abnormal production of plasma cells, although their pathological mechanism of each disease is different. The main character...

    Authors: Ruonan Xu, Ying Fang, Chunmei Hou, Bing Zhai, Zhenyu Jiang, Ning Ma, Liang Wang, Gencheng Han and Renxi Wang
    Citation: Cancer Cell International 2018 18:138
  44. Following publication of the original article [1], the authors reported a typing mistake in the title. In this Correction the incorrect and correct titles are shown.

    Authors: Lujun Chen, Jun Feng, Bin Xu, You Zhou, Xiao Zheng, Changping Wu and Jingting Jiang
    Citation: Cancer Cell International 2018 18:134

    The original article was published in Cancer Cell International 2018 18:126

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2023 Speed
    34 days submission to first editorial decision for all manuscripts (Median)
    110 days submission to accept (Median)

    2023 Usage 
    2,067,719 downloads
    1,052 Altmetric mentions 

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here